Log in
Sign Up. It's Free
Last Update: Oct, 28 2024
Overview
Dosage & Administration
Coverage
Drug label
PubMed™ News
FAQ
Votrient
(pazopanib)
DOSAGE FORMS & STRENGTHS
BOXED WARNING
See your patient’s PA requirements and coverage rules for
Votrient
Get Coverage Information
Dosage & Administration
*
Recommended Dosage
: 800 mg orally once daily without food (at least 1 hour before or 2 hours after a meal).
*
Moderate Hepatic Impairment
: 200 mg orally once daily.
Get Your Patient on Votrient
See your patient's specific prior authorization requirements including coverage restrictions and step therapies
Insurance Carrier
Or select your Insurance from the list below:
UnitedHealthcare (UHC)
Aetna Health
CIGNA
Anthem Blue Cross and Blue Shield
TRICARE
Humana
Wellcare Health Plans
FEPBlue
VHA
UHC Community Plan
Votrient Prescribing Information
Report Adverse Event
Votrient PubMed™ News
Last year
Publication date
Article Type
Format
5 articles
Reset Filters
Votrient FAQs
How is the dosage of Votrient?
Votrient is available in 1 dosages, including 200 mg Tab
What does Votrient treat?
Votrient treats Carcinoma, Renal Cell and Soft Tissue Neoplasms
What is Votrient made of?
Votrient contains pazopanib which is a Kinase Inhibitor
How Is Votrient Administered?
Votrient is administered as a Oral Pill
What Are The Votrient Mechanism Of Action?
Votrient mechanism of action is Protein Kinase Inhibitors, Cytochrome P450 2D6 Inhibitors, Cytochrome P450 3A4 Inhibitors or Cytochrome P450 2C8 Inhibitors
FAQ Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available